Characterization of the binding of Cu(II) and Zn(II) to transthyretin: Effects on amyloid formation

Biochemistry

Volumn 46, Issue 31, 2007, Pages 9123-9132

  Wilkinson White, Lorna E ^a   Easterbrook Smith, Simon B ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; DOSIMETRY; FLUORESCENCE; PH EFFECTS;

DOSE-DEPENDENT QUENCHING; TRANSTHYRETIN;

PROTEINS;

8 ANILINO 1 NAPHTHALENESULFONIC ACID; ALUMINUM; AMYLOID PROTEIN; COPPER; FERRIC ION; METAL ION; MUTANT PROTEIN; PREALBUMIN; TETRAMER; TRYPTOPHAN; UREA; ZINC;

ARTICLE; CONCENTRATION (PARAMETERS); DISSOCIATION CONSTANT; FLUORESCENCE; MOLECULAR STABILITY; PH; PRIORITY JOURNAL; WILD TYPE;

ALUMINUM; AMINO ACID SUBSTITUTION; AMYLOID; ANILINO NAPHTHALENESULFONATES; BINDING SITES; COPPER; HUMANS; HYDROGEN-ION CONCENTRATION; IRON; KINETICS; PREALBUMIN; PROTEIN BINDING; RECOMBINANT PROTEINS; SPECTROMETRY, FLUORESCENCE; TRYPTOPHAN; ZINC;

EID: 34547803095     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi700607z     Document Type: Article

References (51)

1. Chiti, F., and Dobson, C. M. (2006) Protein misfolding, functional amyloid, and human disease, Annu. Rev. Biochem. 75, 333-366.
2. Dobson, C. M. (2003) Protein folding and misfolding, Nature 426, 884-890.
3. Sunde, M., Serpen, L. C., Bartlam, M., Fraser, P. E., Pepys, M. B., and Blake, C. C. (1997) Common core structure of amyloid fibrils by synchrotron X-ray diffraction, J. Mol. Biol. 273, 729-739.
4. Makin, O. S., Atkins, E., Sikorski, P., Johansson, J., and Serpell, L. C. (2005) Molecular basis for amyloid fibril formation and stability, Proc. Natl. Acad. Sci. U.S.A. 102, 315-320.
5. Blake, C. C., and Oatley, S. J. (1977) Protein-DNA and protein-hormone interactions in prealbumin: a model of the thyroid hormone nuclear receptor? Nature 268, 115-120.
6. Wojtczak, A., Neumann, P., and Cody, V. (2001) Structure of a new polymorphic monoclinic form of human transthyretin at 3 Å resolution reveals a mixed complex between unliganded and T4-bound tetramers of TTR, Acta Crystallogr., Sect. D 57, 957-967.
7. Westermark, P., Sletten, K., Johansson, B., and Cornwell, G. G., III. (1990) Fibril in senile systemic amyloidosis is derived from normal transthyretin, Proc. Natl. Acad. Sci. U.S.A. 87, 2843-2845.
8. Saraiva, M. J. (2001) Transthyretin mutations in hyperthyroxinemia and amyloid diseases, Hum. Mutat. 17, 493-503.
9. Saraiva, M. J. (2001) Transthyretin amyloidosis: a tale of weak interactions, FEBS Lett. 498, 201-203.
10. Hammarstrom, P., Jiang, X., Hurshman, A. R., Powers, E. T., and Kelly, J. W. (2002) Sequence-dependent denaturation energetics: A major determinant in amyloid disease diversity, Proc. Natl. Acad. Sci. U.S.A. 99, 16427-16432.
11. Hammarstrom, P., Schneider, F., and Kelly, J. W. (2001) Transsuppression of misfolding in an amyloid disease, Science 293, 2459-2462.
12. Hammarstrom, P., Wiseman, R. L., Powers, E. T., and Kelly, J. W. (2003) Prevention of transthyretin amyloid disease by changing protein misfolding energetics, Science 299, 713-716.
13. Longo Alves, I., Hays, M. T., and Saraiva, M. J. (1997) Comparative stability and clearance of [Met30]transthyretin and [Met119]transthyretin, Eur. J. Biochem. 249, 662-668.
14. Quintas, A., Vaz, D. C., Cardoso, I., Saraiva, M. J., and Brito, R. M. (2001) Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants, J. Biol. Chem. 276, 27207-27213.
15. Jiang, X., Smith, C. S., Petrassi, H. M., Hammarstrom, P., White, J. T., Sacchettini, J. C., and Kelly, J. W. (2001) An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured, Biochemistry 40, 11442-11452.
16. Lai, Z., Colon, W., and Kelly, J. W. (1996) The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid, Biochemistry 35, 6470-6482.
17. Lashuel, H. A., Wurth, C., Woo, L., and Kelly, J. W. (1999) The most pathogenic transthyretin variant, L55P, forms amyloid fibrils under acidic conditions and protofilaments under physiological conditions, Biochemistry 38, 13560-13573.
18. Atwood, C. S., Moir, R. D., Huang, X., Scarpa, R. C., Bacarra, N. M., Romano, D. M., Hartshorn, M. A., Tanzi, R. E., and Bush, A. I. (1998) Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis, J. Biol. Chem. 273, 12817-12826.
19. Huang, X., Cuajungco, M. P., Atwood, C. S., Hartshorn, M. A., Tyndall, J. D., Hanson, G. R., Stokes, K. C., Leopold, M., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Saunders, A. J., Lim, J., Moir, R. D., Glabe, C., Bowden, E. F., Masters, C. L., Fairlie, D. P., Tanzi, R. E., and Bush, A. I. (1999) Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction, J. Biol. Chem. 274, 37111-37116.
20. Huang, X., Atwood, C. S., Hartshorn, M. A., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Cuajungco, M. P., Gray, D. N., Lim, J., Moir, R. D., Tanzi, R. E., and Bush, A. I. (1999) The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction, Biochemistry 38, 7609-7616.
21. Opazo, C., Huang, X., Cherny, R. A., Moir, R. D., Roher, A. E., White, A. R., Cappai, R., Masters, C. L., Tanzi, R. E., Inestrosa, N. C., and Bush, A. I. (2002) Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2), J. Biol. Chem. 277, 40302-40308.
22. Uversky, V. N., Li, J., and Fink, A. L. (2001) Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure, J. Biol. Chem. 276, 44284-44296.
23. Rasia, R. M., Bertoncini, C. W., Marsh, D., Hoyer, W., Cherny, D., Zweckstetter, M., Griesinger, C., Jovin, T. M., and Fernandez, C. O. (2005) Structural characterization of copper(II) binding to {alpha}-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease, Proc. Natl. Acad. Sci. U.S.A. 102, 4294-4299.
24. Davis, D. P., Gallo, G., Vogen, S. M., Dul, J. L., Sciarretta, K. L., Kumar, A., Raffen, R., Stevens, F. J., and Argon, Y. (2001) Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain, J. Mol. Biol. 313, 1021-1034.
25. Jobling, M. F., Huang, X., Stewart, L. R., Barnham, K. J., Curtain, C., Volitakis, I., Perugini, M., White, A. R., Cherny, R. A., Masters, C. L., Barrow, C. J., Collins, S. J., Bush, A. I., and Cappai, R. (2001) Copper and zinc binding modulates the aggregation and neurotoxic properties of the prion peptide PrP106-126, Biochemistry 40, 8073-8084.
26. Brown, D. R., Qin, K., Herms, J. W., Madlung, A., Manson, J., Strome, R., Fraser, P. E., Kmck, T., von Bohlen, A., Schulz-Schaeffer, W., Giese, A., Westaway, D., and Kretzschmar, H. (1997) The cellular prion protein binds copper in vivo, Nature 390, 684-687.
27. Bocharova, O. V., Breydo, L., Salnikov, V. V., and Baskakov, I. V. (2005) Copper(II) inhibits in vitro conversion of prion protein into amyloid fibrils, Biochemistry 44, 6776-6787.
28. Morgan, C. J., Gelfand, M., Atreya, C., and Miranker, A. D. (2001) Kidney dialysis-associated amyloidosis: a molecular role for copper in fiber formation, J. Mol. Biol. 309, 339-345.
29. Eakin, C. M., Knight, J. D., Morgan, C. J., Gelfand, M. A., and Miranker, A. D. (2002) Formation of a copper specific binding site in non-native states of beta-2-microglobulin, Biochemistry 41, 10646-10656.
30. Jones, S., Smith, D. P., and Radford, S. E. (2003) Role of the N and C-terminal strands of beta 2-microglobulin in amyloid formation at neutral pH, J. Mol. Biol. 330, 935-941.
31. Eakin, C. M., Berman, A. J., and Miranker, A. D. (2006) A native to amyloidogenic transition regulated by a backbone trigger, Nat. Struct. Mol. Biol. 13, 202-208.
32. Deng, N. J., Yan, L., Singh, D., and Cieplak, P. (2006) Molecular basis for the Cu2+ binding-induced destabilization of beta2-microglobulin revealed by molecular dynamics simulation, Biophys. J. 90, 3865-3879.
33. Andersson, K., Olofsson, A., Nielsen, E. H., Svehag, S. E., and Lundgren, E. (2002) Only amyloidogenic intermediates of transthyretin induce apoptosis, Biochem. Biophys. Res. Commun. 294, 309-314.
34. Colon, W., and Kelly, J. W. (1992) Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro, Biochemistry 31, 8654-8660.
35. Hammarstrom, P., Jiang, X., Deechongkit, S., and Kelly, J. W. (2001) Anion shielding of electrostatic repulsions in transthyretin modulates stability and amyloidosis: insight into the chaotrope unfolding dichotomy, Biochemistry 40, 11453-11459.
36. Jackson, G. S., Murray, I., Hosszu, L. L., Gibbs, N., Waltho, J. P., Clarke, A. R., and Collinge, J. (2001) Location and properties of metal-binding sites on the human prion protein, Proc. Natl. Acad. Sci. U.S.A. 98, 8531-8535.
37. Quintas, A., Saraiva, M. J., and Brito, R. M. (1999) The tetrameric protein transthyretin dissociates to a non-native monomer in solution. A novel model for amyloidogenesis, J. Biol. Chem. 274, 32943-32949.
38. Cheng, S. Y., Pages, R. A., Saroff, H. A., Edelhoch, H., and Robbins, J. (1977) Analysis of thyroid hormone binding to human serum prealbumin by 8-anilinonaphthalene-1-sulfonate fluorescence, Biochemistry 16, 3707-3713.
39. Nilsson, S. F., Rask, L., and Peterson, P. A. (1975) Studies on thyroid hormone-binding proteins. II. Binding of thyroid hormones, retinol-binding protein, and fluorescent probes to prealbumin and effects of thyroxine on prealbumin subunit self association, J. Biol. Chem. 250, 8554-8563.
40. Smith, T. J., Davis, F. B., Deziel, M. R., Davis, P. J., Ramsden, D. B., and Schoenl, M. (1994) Retinoic acid inhibition of thyroxine binding to human transthyretin, Biochim. Biophys. Acta 1199, 76-80.
41. Bush, A. I., Multhaup, G., Moir, R. D., Williamson, T. G., Small, D. H., Rumble, B., Pollwein, P., Beyreuther, K., and Masters, C. L. (1993) A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease, J. Biol. Chem. 268, 16109-16112.
42. Thompsett, A. R., Abdelraheim, S. R., Daniels, M., and Brown, D. R. (2005) High affinity binding between copper and full-length prion protein identified by two different techniques, J. Biol. Chem. 280, 42750-42758.
43. Dawson, R. M. C., Elliott, D. C., Elliott, D. H., and Jones, K. M. (1986) Data for Biochemical Research, Oxford University Press, Oxford, U.K.
44. Syme, C. D., Nadal, R. C., Rigby, S. E., and Viles, J. H. (2004) Copper binding to the amyloid-beta (Abeta) peptide associated with Alzheimer's disease: folding, coordination geometry, pH dependence, stoichiometry, and affinity of Abeta-(1-28): insights from a range of complementary spectroscopic techniques, J. Biol. Chem. 279, 18169-18177.
45. Ghayour-Mobarhan, M., Taylor, A., New, S. A., Lamb, D. J., and Ferns, G. A. (2005) Determinants of serum copper, zinc and selenium in healthy subjects, Ann. Clin. Biochem. 42, 364-375.
46. Twomey, P. J., Viljoen, A., House, I. M., Reynolds, T. M., and Wierzbicki, A. S. (2005) Relationship between serum copper, ceruloplasmin, and non-ceruloplasmin-bound copper in routine clinical practice, Clin. Chem. 51, 1558-1559.
47. Twomey, P. J., Viljoen, A., House, I. M., Reynolds, T. M., and Wierzbicki, A. S. (2006) Adjusting copper concentrations for caeruloplasmin levels in routine clinical practice, J. Clin. Pathol. 59, 867-869.
48. Bohrer, D., Do Nascimento, P. C., Ramirez, A. G., Mendonca, J. K., De Carvalho, L. M., and Pomblum, S. C. (2004) Comparison of ultrafiltration and solid phase extraction for the separation of free and protein-bound serum copper for the Wilson's disease diagnosis, Clin. Chim. Acta 345, 113-121.
49. Ferguson, R. N., Edelhoch, H., Saroff, H. A., Robbins, J., and Cahnmann, H. J. (1975) Negative cooperativity in the binding of thyroxine to human serum prealbumin. Preparation of tritium-labeled 8-anilino-1-naphthalenesulfonic acid, Biochemistry 14, 282-289.
50. Hurshman, A. R., White, J. T., Powers, E. T., and Kelly, J. W. (2004) Transthyretin aggregation under partially denaturing conditions is a downhill polymerization, Biochemistry 43, 7365-7381.
51. Sato, T., Ando, Y., Susuki, S., Mikami, F., Ikemizu, S., Nakamura, M., Suhr, O., Anraku, M., Kai, T., Suico, M. A., Shuto, T., Mizuguchi, M., Yamagata, Y., and Kai, H. (2006) Chromium-(III) ion and thyroxine cooperate to stabilize the transthyretin tetramer and suppress in vitro amyloid fibril formation, FEBS Lett. 580, 491-496.